Zydus Lifesciences has informed that it enclosed a copy of press release dated April 20, 2023 titled ‘Zydus receives final approval from the USFDA for Metoprolol Tartrate Tablets USP, 25 mg, 50 mg, and 100 mg’.
The above information is a part of company’s filings submitted to BSE.